These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11364918)

  • 41. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?
    Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R;
    Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glaxo opens broad expanded access program for abacavir (Ziagen).
    Baker R
    BETA; 1998 Apr; ():6. PubMed ID: 11365271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CMV trials struggle to enroll.
    Cadman J
    GMHC Treat Issues; 1997 Sep; 11(9):4-5. PubMed ID: 11364750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 1592 - where are you?
    Notes Undergr; 1997; (No 35):1. PubMed ID: 11364562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1592: two studies recruiting.
    AIDS Treat News; 1996 Nov; (No 259):3, 6. PubMed ID: 11364000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3TC rules change again.
    GMHC Treat Issues; 1995 May; 9(5):2. PubMed ID: 11362412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethnicity and treatment.
    Proj Inf Perspect; 1997 Jul; (22):15-6. PubMed ID: 11364573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral load: new confirmation from major delavirdine studies.
    James JS
    AIDS Treat News; 1996 Jan; (no 239):2-3. PubMed ID: 11363084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 1592: small distribution programs begin June, July.
    AIDS Treat News; 1997 May; (No 271):5. PubMed ID: 11364368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Merck expanded access program August 11, 1995 deadline.
    Treat Rev; 1995; (no 19):3. PubMed ID: 11362754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GS 840 (adefovir dipivoxil): broad-spectrum antiviral trial, CD4 count under 100.
    James JS
    AIDS Treat News; 1997 Feb; (No 264):4-5. PubMed ID: 11364103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PMPA in perspective.
    James JS
    AIDS Treat News; 1995 Dec; (no 236):5. PubMed ID: 11363050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Three drugs now in expanded access.
    Gilden D
    GMHC Treat Issues; 1997 Oct; 11(10):12. PubMed ID: 11364820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adefovir dipivoxil (Preveon) expanded access begins.
    AIDS Treat News; 1997 Dec; (No 285):5-6. PubMed ID: 11364918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adefovir dipivoxil (Preveon) expanded access restrictions being eased.
    James JS
    AIDS Treat News; 1998 Feb; (No 288):4-5. PubMed ID: 11365045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adefovir dipivoxil (Preveon) improved expanded-access program.
    AIDS Treat News; 1998 Apr; (No 293):6. PubMed ID: 11365388
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.